glp 1 ra medicamentos Factores clave para la pérdida de peso con GLP-1 en pacientes obesos Los medicamentos GLP-1 son una

diarrhea 49% vs

GLP-1 agonists were originally approved to treat Type 2 Diabetes (T2D) but their most recent incarnations, which consist of both next generation GLP-1s and combinations (Ozempic, Mounjaro, Wegovy, Zepbound), have moved beyond the realm of T2D into the treatment of obesity

The study was supported by the UTSW Clinical and Translational Science Award, the National Institutes of Health (1U54TR00236), the Texas Health Resource Clinical Scholar program, and the UTSW Nutrition & Obesity Research Center (NORC)

During your consultation, we will speak with you to discuss your overall aesthetic goals and develop a treatment plan with your provider

If you dont have recent lab work, we coordinate with a lab near you that can perform the blood work and send the results to us

Some plans require a prior authorization, which your prescriber may need to submit before coverage is approved